—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

Although the Sultanate of Oman has a relatively low prevalence of MS (15 cases per 100,000 people) compared to other Gulf countries, understanding the psychological, cognitive, and social ...

Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...

For the first 10 years after Sarah Hwang’s multiple sclerosis diagnosis in 1999, she had a relapsing form of the disorder. Relapses came with blurred vision or numbness in one of her limbs. Then, ...

Read more in the PNW Health series. For decades, when someone in Washington state had to manage multiple sclerosis, care quality often depended on where that person lived. Rural Washingtonians ...